Insight & Strategy

We collaborate with experts and draw on published and unpublished research information. We prepare reports highlighting research trends and opportunities and supporting you in your projects. We help you to take the best decisions to achieve your goals.

Concepts & Implementation

Together with you and experts, we develop concepts and feasibility studies and support you in the implementation.

Digital Health Expertise

We use our experience and networks in the field of Digital Health to advise you: From strategy to the legal and ethical frameworks.

Quality Assurance & Scientific Due Diligence

We carry out structured audits and evaluations of institutions and programs. We help you to assess the degree of innovation and potential of scientific and technical projects and portfolios.

Insight & Strategy

Insight

We collaborate with experts and draw on published and unpublished research information to produce reports that highlight research trends and opportunities. Literature analyses are merely starting points. We interview the experts in a field with tailored questions and develop together with them in-depth insights. We derive opportunities and options for action.

Strategy

We take the time to understand your situation and challenges, using our local and global knowledge to challenge conventions and develop strategies that are tailored to your specific needs. We help you take the best decisions to achieve your goals.

Prävention in der Gesundheits­versorgung verankern: Zentrale Dimensionen und Case Studies

Study in collaboration with advocacy AG, for the Federal Office of Public Health FOPH, Prevention Non-communicable diseases Division.

Biomedical research in Switzerland: current situation

Study in collaboration with advocacy AG, for the Swiss Science and Innovation Council SSIC.

Concepts & Implementation

Concepts

Together with you and experts we develop concepts, feasibility studies and study designs in the fields of life sciences, medicine and health.

Implementation

We support you in the implementation, from the generation of applications, study protocols and regulatory documents to stakeholder management.

Grundlagen der Prävention in der Gesundheits­versorgung (PGV) und Konzept Projektförderung PGV

Concept development and interpretative document. Commissioned by: Health Promotion Switzerland and Federal Office of Public Health FOPH.

Concept for a Swiss Tumor Immunology Registry AlpineTIR

Concept development, stakeholder management, redaction of research protocol. Commissioned by: Swiss Tumor Immunology Institute.

Feasibility Study Swiss Competence Center Radiopharmacy

Commissioned by: Paul Scherrer Institute.

Feasibility Study Microbiota Vault

Feasibility study in collaboration with advocacy AG. Commissioned by: Seerave Foundation.

Digital Health

Digital Health

We use our experience and networks in the field of Digital Health to advise you: From strategy to the legal and ethical frameworks. The focus of our work lies at the interfaces of technology, governance, law and ethics.

Concept for a Swiss Tumor Immunology Registry AlpineTIR

Concept development, stakeholder management, redaction of research protocol. Commissioned by: Swiss Tumor Immunology Institute.

MIDATA Cooperative

Management of the MIDATA office.

Quality Assurance & Scientific Due Diligence

Quality Assurance

We carry out structured audits and evaluations of institutions and programs. In terms of developing a quality culture, evaluations help you to review your performance and to optimize it within the framework of existing development processes. The evaluation process comprises a range of instruments, from expert reviews, workshops, site visits by international peer groups, to scientometric analyses. If desired, we combine evaluations and site visits with subsequent strategy consultation.

Scientific Due Diligence

We help you to evaluate the degree of innovation and the potential of scientific and technical projects and portfolios. This service can be combined with our quality assurance services to assess the potential of a research team or institution, to guide the project effectively through development, and to identify ways to strengthen your competitiveness and overcome technical barriers.

Evaluation of the research funding of Swiss Cancer League and Cancer Research Switzerland

The evaluation examined the quality and efficiency of processes, structures and governance, using an “Informed Peer Review” methodology adapted from the evaluation process developed at the University of Zurich.

Evaluation of university departments and faculties

Evaluation of 8 departments/faculties of the University of Basel employing external peer groups.

Scientific Due Diligence Report on a Technology Acquisition for a Biologics Manufacturer

A biologics manufacturer wanted an independent view on the merits of acquiring a company that had developed a novel production technology. We assembled a project team of experts from the UK and the US to work with the client’s R&D experts. A list of questions for the experts were prepared by us in collaboration with the client. The expert’s responses formed the basis of a lively web-ex discussion in which we drilled down to uncover several fundamental concerns about the longterm benefits of the acquisition. The client decided not to acquire the technology, saving many millions, but also developed a more clear definition of the technology they really needed.

Scientific Due Diligence and Commercial Feasibility Report for a Venture Capital Investor

An investment company owning a stake in a publicly listed biotech company in the field of immunology wanted to get an independent opinion on the performance and potential of the company’s individual development programs. EvalueScience was contracted to perform scientific due diligence on the company’s technology and product portfolio.
Das therapeutische Potenzial der immunmodulierenden Programme des Unternehmens in 6 verschiedenen Therapiegebieten wurde von 7 EvalueScience-Experten bewertet. Während die wissenschaftliche Due Diligence und der kommerzielle Machbarkeitsbericht die firmeneigene Technologieplattform sehr hoch bewerteten, wurde empfohlen, sich auf ein einziges Programm im aussichtsreichsten Bereich zu konzentrieren und die anderen Programme zu stoppen oder auszulizenzieren. Der Investor übergab den Bericht an das Unternehmen. Der Bericht trug zu der Entscheidung des Unternehmens bei, sich auf dieses Programm zu konzentrieren.